Vault-13

Bellevue Group AG

ZURICH, V8 · CIK 1674546 · 13F filing filed 2023-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Other 13F filers in this group: Bellevue Asset Management AG files a notice

$7.0bn reported value +1.7% vs Q1 2023
156positions
36.6%in top 10
9 new 52 added 52 reduced 12 sold out vs Q1 2023

This report includes the holdings of 3 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 1,097,166 $386.1m5.51% 5.51% ReducedShares held: Q3 2022 1.2m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m -48.5k -48,529 -4.2%
2 IONIS PHARMACEUTICALS INC COM IONS IONS 9,380,300 $384.9m5.49% 5.49% ReducedShares held: Q3 2022 9.5m, Q4 2022 9.7m, Q1 2023 9.5m, Q2 2023 9.4m -131.6k -131,600 -1.4%
3 ARGENX SE SPONSORED ADR ARGX ARGX 923,284 $359.8m5.13% 5.13% AddedShares held: Q3 2022 919.3k, Q4 2022 911.1k, Q1 2023 886.9k, Q2 2023 923.3k +36.4k +36,356 4.1%
4 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 842,224 $288.0m4.11% 4.11% ReducedShares held: Q3 2022 898.1k, Q4 2022 957.1k, Q1 2023 968.8k, Q2 2023 842.2k -126.6k -126,562 -13.1%
5 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 2,612,800 $246.4m3.51% 3.51% ReducedShares held: Q3 2022 2.9m, Q4 2022 2.8m, Q1 2023 2.6m, Q2 2023 2.6m -500 -500 -0.0%
6 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 3,201,800 $202.7m2.89% 2.89% ReducedShares held: Q3 2022 3.3m, Q4 2022 3.3m, Q1 2023 3.3m, Q2 2023 3.2m -66.2k -66,200 -2.0%
7 MODERNA INC COM MRNA MRNA 1,525,059 $185.3m2.64% 2.64% ReducedShares held: Q3 2022 1.6m, Q4 2022 1.6m, Q1 2023 1.6m, Q2 2023 1.5m -26.6k -26,647 -1.7%
8 ABBOTT LABS COM ABT ABT 1,646,501 $179.5m2.56% 2.56% ReducedShares held: Q3 2022 1.6m, Q4 2022 1.7m, Q1 2023 1.6m, Q2 2023 1.6m -415 -415 -0.0%
9 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 899,650 $170.9m2.44% 2.44% AddedShares held: Q3 2022 956.8k, Q4 2022 921.2k, Q1 2023 883.2k, Q2 2023 899.6k +16.4k +16,400 1.9%
10 INCYTE CORP COM INCY INCY 2,640,765 $164.4m2.34% 2.34% ReducedShares held: Q3 2022 2.7m, Q4 2022 3.0m, Q1 2023 2.8m, Q2 2023 2.6m -199.7k -199,735 -7.0%
11 SAGE THERAPEUTICS INC COM SAGE SAGE 3,114,375 $146.4m2.09% 2.09% AddedShares held: Q3 2022 3.0m, Q4 2022 3.0m, Q1 2023 3.1m, Q2 2023 3.1m +24.4k +24,375 0.8%
12 STRYKER CORPORATION COM SYK SYK 476,946 $145.5m2.08% 2.08% ReducedShares held: Q3 2022 476.9k, Q4 2022 492.2k, Q1 2023 484.8k, Q2 2023 476.9k -7.8k -7,828 -1.6%
13 BOSTON SCIENTIFIC CORP COM BSX BSX 2,661,452 $144.0m2.05% 2.05% ReducedShares held: Q3 2022 3.8m, Q4 2022 3.9m, Q1 2023 3.4m, Q2 2023 2.7m -778.1k -778,127 -22.6%
14 REVOLUTION MEDICINES INC COM RVMD RVMD 4,746,000 $127.0m1.81% 1.81% ReducedShares held: Q3 2022 4.7m, Q4 2022 4.9m, Q1 2023 4.7m, Q2 2023 4.7m -1.9k -1,900 -0.0%
15 MEDTRONIC PLC SHS MDT MDT 1,410,492 $124.3m1.77% 1.77% AddedShares held: Q3 2022 615.9k, Q4 2022 618.4k, Q1 2023 1.2m, Q2 2023 1.4m +181.3k +181,257 14.8%
16 INSPIRE MED SYS INC COM INSP INSP 357,020 $115.9m1.65% 1.65% ReducedShares held: Q3 2022 401.8k, Q4 2022 401.7k, Q1 2023 377.1k, Q2 2023 357.0k -20.0k -20,048 -5.3%
17 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 4,013,500 $113.7m1.62% 1.62% UnchangedShares held: Q3 2022 4.1m, Q4 2022 4.1m, Q1 2023 4.0m, Q2 2023 4.0m
18 AXONICS INC COM AXNX AXNX 2,223,418 $112.2m1.60% 1.60% AddedShares held: Q3 2022 2.2m, Q4 2022 1.9m, Q1 2023 1.9m, Q2 2023 2.2m +311.6k +311,557 16.3%
19 EVOLENT HEALTH INC CL A EVH EVH 3,448,322 $104.5m1.49% 1.49% AddedShares held: Q3 2022 1.9m, Q4 2022 2.0m, Q1 2023 2.2m, Q2 2023 3.4m +1.3m +1,257,175 57.4%
20 UNITEDHEALTH GROUP INC COM UNH UNH 210,127 $101.0m1.44% 1.44% AddedShares held: Q3 2022 296.8k, Q4 2022 224.3k, Q1 2023 194.8k, Q2 2023 210.1k +15.3k +15,316 7.9%
21 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 7,542,829 $100.3m1.43% 1.43% AddedShares held: Q3 2022 5.4m, Q4 2022 6.5m, Q1 2023 7.0m, Q2 2023 7.5m +516.7k +516,723 7.3%
22 EDWARDS LIFESCIENCES CORP COM EW EW 1,038,092 $97.9m1.40% 1.40% ReducedShares held: Q3 2022 1.0m, Q4 2022 1.1m, Q1 2023 1.0m, Q2 2023 1.0m -2.6k -2,577 -0.2%
23 DEXCOM INC COM DXCM DXCM 761,716 $97.9m1.40% 1.40% AddedShares held: Q3 2022 860.5k, Q4 2022 988.5k, Q1 2023 755.1k, Q2 2023 761.7k +6.6k +6,637 0.9%
24 EXACT SCIENCES CORP COM EXAS EXAS 1,006,772 $94.5m1.35% 1.35% ReducedShares held: Q3 2022 1.1m, Q4 2022 1.3m, Q1 2023 1.2m, Q2 2023 1.0m -218.3k -218,270 -17.8%
25 INSULET CORP COM PODD PODD 323,594 $93.3m1.33% 1.33% UnchangedShares held: Q3 2022 374.0k, Q4 2022 345.8k, Q1 2023 323.6k, Q2 2023 323.6k
26 BECTON DICKINSON & CO COM BDX BDX 337,723 $89.2m1.27% 1.27% ReducedShares held: Q3 2022 334.8k, Q4 2022 331.6k, Q1 2023 348.0k, Q2 2023 337.7k -10.3k -10,320 -3.0%
27 PENUMBRA INC COM PEN PEN 234,220 $80.6m1.15% 1.15% ReducedShares held: Q3 2022 189.8k, Q4 2022 225.8k, Q1 2023 238.2k, Q2 2023 234.2k -4.0k -3,952 -1.7%
28 SHOCKWAVE MED INC COM SWAV SWAV 270,526 $77.2m1.10% 1.10% ReducedShares held: Q3 2022 276.1k, Q4 2022 247.6k, Q1 2023 281.4k, Q2 2023 270.5k -10.8k -10,850 -3.9%
29 OPTION CARE HEALTH INC COM NEW OPCH OPCH 2,287,623 $74.3m1.06% 1.06% ReducedShares held: Q3 2022 2.6m, Q4 2022 2.4m, Q1 2023 2.4m, Q2 2023 2.3m -154.6k -154,562 -6.3%
30 INSMED INC COM PAR $.01 INSM INSM 3,300,911 $69.6m0.99% 0.99% AddedShares held: Q3 2022 3.2m, Q4 2022 3.3m, Q1 2023 3.3m, Q2 2023 3.3m +7.8k +7,809 0.2%
31 OUTSET MED INC COM OM OM 3,125,886 $68.4m0.98% 0.98% AddedShares held: Q3 2022 2.4m, Q4 2022 2.8m, Q1 2023 2.9m, Q2 2023 3.1m +219.1k +219,127 7.5%
32 CHARLES RIV LABS INTL INC COM CRL CRL 314,513 $66.1m0.94% 0.94% AddedShares held: Q3 2022 263.0k, Q4 2022 290.0k, Q1 2023 302.4k, Q2 2023 314.5k +12.1k +12,067 4.0%
33 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 1,800,000 $61.1m0.87% 0.87% UnchangedShares held: Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 1.8m
34 ACCOLADE INC COM ACCD ACCD 4,521,059 $60.9m0.87% 0.87% AddedShares held: Q3 2022 3.6m, Q4 2022 3.7m, Q1 2023 4.0m, Q2 2023 4.5m +479.3k +479,258 11.9%
35 ALIGN TECHNOLOGY INC COM ALGN ALGN 171,140 $60.5m0.86% 0.86% UnchangedShares held: Q3 2022 74.9k, Q4 2022 79.2k, Q1 2023 171.1k, Q2 2023 171.1k
36 IDEXX LABS INC COM IDXX IDXX 114,441 $57.5m0.82% 0.82% AddedShares held: Q3 2022 108.8k, Q4 2022 108.8k, Q1 2023 110.9k, Q2 2023 114.4k +3.5k +3,513 3.2%
37 HUMANA INC COM HUM HUM 127,373 $57.0m0.81% 0.81% AddedShares held: Q3 2022 134.2k, Q4 2022 110.5k, Q1 2023 68.6k, Q2 2023 127.4k +58.8k +58,803 85.8%
38 VEEVA SYS INC CL A COM VEEV VEEV 271,046 $53.6m0.76% 0.76% AddedShares held: Q3 2022 157.6k, Q4 2022 186.3k, Q1 2023 263.0k, Q2 2023 271.0k +8.1k +8,061 3.1%
39 ARVINAS INC COM ARVN ARVN 2,127,000 $52.8m0.75% 0.75% UnchangedShares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.1m, Q2 2023 2.1m
40 RELAY THERAPEUTICS INC COM RLAY RLAY 4,170,800 $52.4m0.75% 0.75% ReducedShares held: Q3 2022 4.2m, Q4 2022 4.2m, Q1 2023 4.2m, Q2 2023 4.2m -1.8k -1,800 -0.0%
41 TRANSMEDICS GROUP INC COM TMDX TMDX 612,613 $51.4m0.73% 0.73% ReducedShares held: Q3 2022 653.8k, Q4 2022 682.1k, Q1 2023 629.5k, Q2 2023 612.6k -16.9k -16,871 -2.7%
42 MACROGENICS INC COM MGNX MGNX 9,609,913 $51.4m0.73% 0.73% UnchangedShares held: Q3 2022 7.3m, Q4 2022 9.0m, Q1 2023 9.6m, Q2 2023 9.6m
43 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 2,092,934 $51.4m0.73% 0.73% AddedShares held: Q3 2022 1.6m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 2.1m +299.2k +299,171 16.7%
44 BIO RAD LABS INC CL A BIO BIO 134,533 $51.0m0.73% 0.73% AddedShares held: Q3 2022 101.8k, Q4 2022 111.2k, Q1 2023 113.7k, Q2 2023 134.5k +20.8k +20,794 18.3%
45 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 899,300 $50.5m0.72% 0.72% ReducedShares held: Q3 2022 928.3k, Q4 2022 911.7k, Q1 2023 899.8k, Q2 2023 899.3k -500 -500 -0.1%
46 THERMO FISHER SCIENTIFIC INC COM TMO TMO 96,101 $50.1m0.72% 0.72% AddedShares held: Q3 2022 72.1k, Q4 2022 83.3k, Q1 2023 86.3k, Q2 2023 96.1k +9.8k +9,768 11.3%
47 MOLINA HEALTHCARE INC COM MOH MOH 164,338 $49.5m0.71% 0.71% AddedShares held: Q3 2022 240.6k, Q4 2022 186.0k, Q1 2023 142.6k, Q2 2023 164.3k +21.7k +21,729 15.2%
48 HCA HEALTHCARE INC COM HCA HCA 160,515 $48.7m0.69% 0.69% ReducedShares held: Q3 2022 285.8k, Q4 2022 331.3k, Q1 2023 303.8k, Q2 2023 160.5k -143.3k -143,271 -47.2%
49 EXELIXIS INC COM EXEL EXEL 2,534,000 $48.4m0.69% 0.69% ReducedShares held: Q3 2022 2.7m, Q4 2022 2.7m, Q1 2023 2.6m, Q2 2023 2.5m -75.0k -75,000 -2.9%
50 APELLIS PHARMACEUTICALS INC COM APLS APLS 518,495 $47.2m0.67% 0.67% ReducedShares held: Q3 2022 1.0m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 518.5k -590.9k -590,887 -53.3%
51 ELEVANCE HEALTH INC COM ELV ELV 102,453 $45.5m0.65% 0.65% AddedShares held: Q3 2022 202.5k, Q4 2022 149.4k, Q1 2023 93.0k, Q2 2023 102.5k +9.5k +9,483 10.2%
52 ELI LILLY & CO COM LLY LLY 95,155 $44.6m0.64% 0.64% AddedShares held: Q3 2022 9.5k, Q4 2022 11.1k, Q1 2023 10.8k, Q2 2023 95.2k +84.4k +84,391 784.0%
53 DANAHER CORPORATION COM DHR DHR 183,709 $44.1m0.63% 0.63% ReducedShares held: Q3 2022 367.4k, Q4 2022 366.4k, Q1 2023 337.4k, Q2 2023 183.7k -153.7k -153,682 -45.5%
54 SILK RD MED INC COM SILK SILK 1,356,763 $44.1m0.63% 0.63% AddedShares held: Q3 2022 1.0m, Q4 2022 1.0m, Q1 2023 1.1m, Q2 2023 1.4m +287.0k +287,024 26.8%
55 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 284,835 $41.5m0.59% 0.59% AddedShares held: Q3 2022 265.3k, Q4 2022 266.3k, Q1 2023 265.3k, Q2 2023 284.8k +19.6k +19,565 7.4%
56 AXSOME THERAPEUTICS INC COM AXSM AXSM 574,363 $41.3m0.59% 0.59% AddedShares held: Q3 2022 496.5k, Q4 2022 436.7k, Q1 2023 441.4k, Q2 2023 574.4k +133.0k +133,013 30.1%
57 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 8,135,839 $41.1m0.59% 0.59% AddedShares held: Q3 2022 4.7m, Q4 2022 5.4m, Q1 2023 5.4m, Q2 2023 8.1m +2.7m +2,740,000 50.8%
58 GLOBUS MED INC CL A GMED GMED 647,645 $38.6m0.55% 0.55% UnchangedShares held: Q3 2022 647.2k, Q4 2022 680.2k, Q1 2023 647.6k, Q2 2023 647.6k
59 ATRICURE INC COM ATRC ATRC 748,613 $37.0m0.53% 0.53% AddedShares held: Q3 2022 642.4k, Q4 2022 644.1k, Q1 2023 647.2k, Q2 2023 748.6k +101.4k +101,391 15.7%
60 IQVIA HLDGS INC COM IQV IQV 162,120 $36.4m0.52% 0.52% ReducedShares held: Q3 2022 160.2k, Q4 2022 183.3k, Q1 2023 172.5k, Q2 2023 162.1k -10.4k -10,358 -6.0%
61 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 288,779 $35.8m0.51% 0.51% ReducedShares held: Q3 2022 823.8k, Q4 2022 756.6k, Q1 2023 569.9k, Q2 2023 288.8k -281.1k -281,078 -49.3%
62 MERCK & CO INC COM MRK MRK 306,694 $35.4m0.50% 0.50% AddedShares held: Q3 2022 4.8k, Q4 2022 6.8k, Q1 2023 7.1k, Q2 2023 306.7k +299.6k +299,619 4234.9%
63 COOPER COS INC COM NEW COM NEW 86,567 $33.2m0.47% 0.47% AddedShares held: Q3 2022 81.3k, Q4 2022 81.3k, Q1 2023 81.3k, Q2 2023 86.6k +5.3k +5,254 6.5%
64 CAREDX INC COM CDNA CDNA 3,716,477 $31.6m0.45% 0.45% AddedShares held: Q3 2022 2.6m, Q4 2022 3.2m, Q1 2023 3.4m, Q2 2023 3.7m +277.4k +277,386 8.1%
65 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 360,604 $31.3m0.45% 0.45% AddedShares held: Q3 2022 53.5k, Q4 2022 60.7k, Q1 2023 48.4k, Q2 2023 360.6k +312.2k +312,159 644.4%
66 PRIVIA HEALTH GROUP INC COM PRVA PRVA 1,122,644 $29.3m0.42% 0.42% AddedShares held: Q3 2022 515.0k, Q4 2022 900.7k, Q1 2023 1.0m, Q2 2023 1.1m +120.0k +120,000 12.0%
67 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 741,517 $26.2m0.37% 0.37% UnchangedShares held: Q3 2022 589.3k, Q4 2022 741.5k, Q1 2023 741.5k, Q2 2023 741.5k
68 HOLOGIC INC COM HOLX HOLX 290,136 $23.5m0.34% 0.34% UnchangedShares held: Q3 2022 251.4k, Q4 2022 243.2k, Q1 2023 290.1k, Q2 2023 290.1k
69 FATE THERAPEUTICS INC COM FATE FATE 4,855,779 $23.1m0.33% 0.33% UnchangedShares held: Q3 2022 3.7m, Q4 2022 4.9m, Q1 2023 4.9m, Q2 2023 4.9m
70 SAREPTA THERAPEUTICS INC COM SRPT SRPT 200,220 $22.9m0.33% 0.33% ReducedShares held: Q3 2022 755.9k, Q4 2022 693.2k, Q1 2023 646.6k, Q2 2023 200.2k -446.4k -446,394 -69.0%
71 BEAM THERAPEUTICS INC COM BEAM BEAM 695,421 $22.2m0.32% 0.32% UnchangedShares held: Q3 2022 571.7k, Q4 2022 696.7k, Q1 2023 695.4k, Q2 2023 695.4k
72 HUTCHMED CHINA LTD SPONSORED ADS HCM HCM 1,805,583 $21.7m0.31% 0.31% ReducedShares held: Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 1.8m -21.4k -21,387 -1.2%
73 OMNICELL COM COM OMCL OMCL 293,345 $21.6m0.31% 0.31% ReducedShares held: Q3 2022 414.3k, Q4 2022 518.4k, Q1 2023 463.4k, Q2 2023 293.3k -170.0k -170,022 -36.7%
74 RESMED INC COM RMD RMD 98,275 $21.5m0.31% 0.31% UnchangedShares held: Q3 2022 84.6k, Q4 2022 98.3k, Q1 2023 98.3k, Q2 2023 98.3k
75 AMEDISYS INC COM AMED AMED 234,318 $21.4m0.31% 0.31% ReducedShares held: Q3 2022 598.9k, Q4 2022 613.5k, Q1 2023 542.6k, Q2 2023 234.3k -308.3k -308,298 -56.8%
76 ESSA PHARMA INC COM NEW EPI EPI 7,898,583 $21.3m0.30% 0.30% UnchangedShares held: Q3 2022 5.9m, Q4 2022 7.9m, Q1 2023 7.9m, Q2 2023 7.9m
77 GENERATION BIO CO COM COM 3,620,280 $19.9m0.28% 0.28% UnchangedShares held: Q3 2022 3.6m, Q4 2022 3.6m, Q1 2023 3.6m, Q2 2023 3.6m
78 PHREESIA INC COM PHR PHR 638,653 $19.8m0.28% 0.28% UnchangedShares held: Q3 2022 666.4k, Q4 2022 666.4k, Q1 2023 638.7k, Q2 2023 638.7k
79 CENTENE CORP DEL COM CNC CNC 292,527 $19.7m0.28% 0.28% ReducedShares held: Q3 2022 528.4k, Q4 2022 693.6k, Q1 2023 549.3k, Q2 2023 292.5k -256.8k -256,814 -46.8%
80 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 650,256 $19.5m0.28% 0.28% AddedShares held: Q3 2022 119.3k, Q4 2022 111.0k, Q1 2023 122.9k, Q2 2023 650.3k +527.4k +527,375 429.2%
81 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 275,754 $19.0m0.27% 0.27% ReducedShares held: Q3 2022 625.5k, Q4 2022 354.8k, Q1 2023 507.3k, Q2 2023 275.8k -231.5k -231,500 -45.6%
82 10X GENOMICS INC CL A COM TXG TXG 324,746 $18.1m0.26% 0.26% UnchangedShares held: Q3 2022 254.1k, Q4 2022 324.7k, Q1 2023 324.7k, Q2 2023 324.7k
83 MERSANA THERAPEUTICS INC COM COM 5,219,425 $17.2m0.24% 0.24% AddedShares held: Q3 2022 4.1m, Q4 2022 4.3m, Q1 2023 4.3m, Q2 2023 5.2m +919.8k +919,806 21.4%
84 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 4,494,458 $16.4m0.23% 0.23% UnchangedShares held: Q3 2022 4.5m, Q4 2022 4.5m, Q1 2023 4.5m, Q2 2023 4.5m
85 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 2,140,025 $16.1m0.23% 0.23% UnchangedShares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.1m, Q2 2023 2.1m
86 ILLUMINA INC COM ILMN ILMN 84,026 $15.8m0.22% 0.22% ReducedShares held: Q3 2022 85.9k, Q4 2022 94.9k, Q1 2023 99.3k, Q2 2023 84.0k -15.2k -15,231 -15.3%
87 CASTLE BIOSCIENCES INC COM CSTL CSTL 1,124,043 $15.4m0.22% 0.22% AddedShares held: Q3 2022 941.9k, Q4 2022 944.3k, Q1 2023 948.9k, Q2 2023 1.1m +175.2k +175,165 18.5%
88 DOXIMITY INC CL A DOCS DOCS 448,579 $15.3m0.22% 0.22% UnchangedShares held: Q3 2022 193.4k, Q4 2022 448.6k, Q1 2023 448.6k, Q2 2023 448.6k
89 THE CIGNA GROUP COM CI CI 50,399 $14.1m0.20% 0.20% ReducedShares held: Q3 2022 188.7k, Q4 2022 158.6k, Q1 2023 53.5k, Q2 2023 50.4k -3.1k -3,077 -5.8%
90 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 572,315 $12.1m0.17% 0.17% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 262.7k, Q2 2023 572.3k +309.6k +309,632 117.9%
91 REGENERON PHARMACEUTICALS COM REGN REGN 16,327 $11.7m0.17% 0.17% AddedShares held: Q3 2022 17.4k, Q4 2022 15.7k, Q1 2023 15.3k, Q2 2023 16.3k +1.0k +1,011 6.6%
92 POINT BIOPHARMA GLOBAL INC COM COM 1,256,197 $11.4m0.16% 0.16% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.3m
93 NATERA INC COM NTRA NTRA 232,775 $11.3m0.16% 0.16% UnchangedShares held: Q3 2022 0, Q4 2022 173.8k, Q1 2023 232.8k, Q2 2023 232.8k
94 TELADOC HEALTH INC COM TDOC TDOC 392,264 $9.9m0.14% 0.14% ReducedShares held: Q3 2022 390.3k, Q4 2022 390.3k, Q1 2023 432.7k, Q2 2023 392.3k -40.5k -40,457 -9.3%
95 BAXTER INTL INC COM BAX BAX 213,434 $9.7m0.14% 0.14% ReducedShares held: Q3 2022 319.5k, Q4 2022 320.7k, Q1 2023 273.6k, Q2 2023 213.4k -60.2k -60,180 -22.0%
96 GILEAD SCIENCES INC COM GILD GILD 112,650 $8.7m0.12% 0.12% AddedShares held: Q3 2022 97.9k, Q4 2022 130.3k, Q1 2023 100.4k, Q2 2023 112.7k +12.3k +12,294 12.2%
97 BIOGEN INC COM BIIB BIIB 25,598 $7.3m0.10% 0.10% AddedShares held: Q3 2022 28.7k, Q4 2022 28.4k, Q1 2023 24.7k, Q2 2023 25.6k +894 +894 3.6%
98 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 85,600 $6.1m0.09% 0.09% AddedShares held: Q3 2022 44.4k, Q4 2022 68.5k, Q1 2023 71.6k, Q2 2023 85.6k +14.0k +14,000 19.6%
99 AMGEN INC COM AMGN AMGN 27,310 $6.1m0.09% 0.09% ReducedShares held: Q3 2022 45.2k, Q4 2022 38.9k, Q1 2023 38.4k, Q2 2023 27.3k -11.1k -11,057 -28.8%
100 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 4,208,264 $5.8m0.08% 0.08% UnchangedShares held: Q3 2022 4.2m, Q4 2022 4.3m, Q1 2023 4.2m, Q2 2023 4.2m

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
PFIZER INC PFE PFE 740,695 $30.2m740.7k shares
HALOZYME THERAPEUTICS INC HALO HALO 742,400 $28.4m742.4k shares
BIONTECH SE BNTX BNTX 196,480 $24.5m196.5k shares
HARMONY BIOSCIENCES HLDGS IN HRMY HRMY 598,046 $19.5m598.0k shares
ZAI LAB LTD ZLAB ZLAB 159,400 $5.3m159.4k shares
IVERIC BIO INC OPHT OPHT 52,900 $1.3m52.9k shares
CARDINAL HEALTH INC CAH CAH 10,600 $800.3k10.6k shares
XENCOR INC XNCR XNCR 25,400 $708.4k25.4k shares
OPTHEA LTD CYVNY CYVNY 47,000 $186.1k47.0k shares
IPG PHOTONICS CORP IPGP IPGP 1,050 $129.5k1.1k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 1,496 $103.7k1.5k shares
HENRY SCHEIN INC HSIC HSIC 1,043 $85.0k1.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-05-15 VRDN 6.6%≈ $123.6m new 13G 2026-05-15
IMMUNOCORE HLDGS PLC IMCR · 13G · filed 2025-11-14 IMCR 5.6% new 13G 2025-11-14
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-08-14 JBIO 5.0%≈ $67.9m -1.8 pts 13G 2026-08-14